Dr. Rangashree Varadarajan, MD

Dr. Varadarajan practices at Fremont Dialysis in Hayward, California.

Dr. Varadarajan's NPI, 1164884623, was assigned on March 24, 2016. Dr. Varadarajan graduated from St. George's University School of Medicine in 2014. Dr. Varadarajan holds California license A161306.

Dr. Varadarajan's primary practice is Fremont Dialysis, at 27303 Sleepy Hollow S Ave, Hayward, CA 94545 in Alameda County. The practice phone is (510) 796-4385.

Dr. Varadarajan's primary practice is Fremont Dialysis in Hayward, California. Dr. Varadarajan is also affiliated with San Leandro Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Varadarajan to 1 more hospital, 2 dialysis centers, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varadarajan practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Varadarajan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Varadarajan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Varadarajan is licensed in California.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney disease among the conditions Dr. Varadarajan treats.

CMS data shows 91 Medicare services from Dr. Varadarajan across 2 procedure codes in 2024, for 63 Medicare patients. Medicare paid $8,911 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 63 Medicare patients who saw Dr. Varadarajan in 2024. The largest group is under 65, with 26 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 7.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Varadarajan's median patient age at 69, with 47% women.

In 2024, Dr. Varadarajan wrote 1,195 Medicare Part D claims for 301 patients. 88% of them were for generic drugs. CMS names the drug for 956 of them, across 34 drugs with 11 or more claims each, at $88,140 in total drug cost. In 2023, CMS named 1,065 claims across 35 drugs.

Dr. Varadarajan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 13 general payments to Dr. Varadarajan from 3 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 86% of the total. Travere Therapeutics, Inc. paid the most, $53.

Dr. Varadarajan graduated from St. George's University School of Medicine in 2014. Dr. Varadarajan is a member of ACP and ASN.

Dr. Varadarajan is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Kaiser Permanente and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.